Follow the Zealand Pharma A/S share price and the full management transaction log of the company, a publicly traded company based in Denmark. Shares are listed on the DK market, under the supervision of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Zealand Pharma A/S has published 59 reports. Market capitalisation: €22.2bn. The latest transaction was reported on 28 August 2026 (Sale). The full history is accessible without an account.
59
Insider Decl.
n/a
Thresholds
€341,229
5 ops.
Buy Volume
€6m
19 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Zealand Pharma A/S Buy (bullish), based on 14 analysts. Average price target: DKK 441.93.
25Σ signal
Buys €341,229€6m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26 of 29,063 companies
94.9
score / 100
Value
97
Quality
93
FCF yld32%
Earn yld32%
EV/EBITDA2.9x
ROE16%
Gross mgn100%
Net mgn70%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,500 shares@ DKK 224.400.0016% mcap0.1% of flowShareOutside trading venueISINISIN DK0060257814DK:1247975
25 of 59 declarations
Acerca de Zealand Pharma A/S
Zealand Pharma A/S es una empresa biofarmacéutica danesa centrada en el desarrollo de tratamientos para enfermedades metabólicas y endocrinas. Pone énfasis en la innovación en el campo de los péptidos terapéuticos.